You are here

Szöőr Árpád

Szöőr Árpád

Name: Szöőr Árpád
Other profiles: Google Scholar, MTMT
Profession: physician

Publication list

Uploaded publications:
38
Publications in DEA:
37
OA:
24
Date range:
2005-2024
2024
  1. Lupsa, N., Érsek, B., Böröczky, C., Kis, D., Szarka, E., Lumniczky, K., Sáfrány, G., Zádori, Z., Szöőr, Á., Buzás, E., Pos, Z.: High sensitivity of host Helios+/Neuropilin-1+ Treg to pretransplant conditioning hampers development of OX40 bright/integrin-β7+ regulatory cells in acute gastrointestinal GvHD.
    Eur. J. Immunol. [Epub ahea dof print]2024.
    Journal metrics:
    Q1 Immunology (2023)
    Q1 Immunology and Allergy (2023)
2023
  1. Barden, M., Holzinger, A., Velas, L., Mezősi-Csaplár, M., Szöőr, Á., Vereb, G., Schütz, G., Hombach, A., Abken, H.: CAR and TCR form individual signaling synapses and do not cross-activate, however, can co-operate in T cell activation.
    Front. Immunol. 14 1-13, 2023.
    Journal metrics:
    Q1 Immunology
    Q1 Immunology and Allergy
2022
  1. Cserepes, M., Nelhűbel, G., Meilinger-Dobra, M., Herczeg, A., Türk, D., Hegedűs, Z., Svajda, L., Rásó, E., Ladányi, A., Csikó, K., Kenessey, I., Szöőr, Á., Vereb, G., Remenár, É., Tóvári, J.: EGFR R521K Polymorphism Is Not a Major Determinant of Clinical Cetuximab Resistance in Head and Neck Cancer.
    Cancers (Basel). 14 (10), 1-15, 2022.
    Journal metrics:
    Q2 Cancer Research
    Q1 Oncology
  2. Bencze, D., Fekete, T., Pfliegler, V., Szöőr, Á., Csoma, E., Szántó, A., Tarr, T., Bácsi, A., Kemény, L., Veréb, Z., Pázmándi, K.: Interactions between the NLRP3-Dependent IL-1β and the Type I Interferon Pathways in Human Plasmacytoid Dendritic Cells.
    Int. J. Mol. Sci. 23 (20), 1-34, 2022.
    Journal metrics:
    Q2 Catalysis
    Q1 Computer Science Applications
    D1 Inorganic Chemistry
    Q1 Medicine (miscellaneous)
    Q2 Molecular Biology
    Q1 Organic Chemistry
    Q1 Physical and Theoretical Chemistry
    D1 Spectroscopy
  3. Blokon-Kogan, D., Levi-Mann, M., Malka-Levy, L., Itzhaki, O., Besser, M., Shiftan, Y., Szöőr, Á., Vereb, G., Gross, G., Abken, H., Weinstein-Marom, H.: Membrane anchored IL-18 linked to constitutively active TLR4 and CD40 improves human T cell antitumor capacities for adoptive cell therapy.
    J Immunother Cancer. 10 (9), 1-12, 2022.
    Journal metrics:
    D1 Cancer Research
    D1 Immunology
    D1 Immunology and Allergy
    D1 Molecular Medicine
    D1 Oncology
    D1 Pharmacology
  4. Guti, E., Regdon, Z., Sturniolo, I., Kiss, A., Kovács, K., Demény, M., Szöőr, Á., Vereb, G., Szöllősi, J., Hegedűs, C., Polgár, Z., Virág, L.: The multitargeted receptor tyrosine kinase inhibitor sunitinib induces resistance of HER2 positive breast cancer cells to trastuzumab-mediated ADCC.
    Cancer Immunol. Immunother. 71 (9), 2151-2168, 2022.
    Journal metrics:
    Q1 Cancer Research
    Q1 Immunology
    Q1 Immunology and Allergy
    D1 Medicine (miscellaneous)
    Q1 Oncology
2021
  1. Varga, Z., Rácz, E., Türk-Mázló, A., Korodi, M., Szabó, A., Molnár, T., Szöőr, Á., Veréb, Z., Bácsi, A., Koncz, G.: Cytotoxic activity of human dendritic cells induces RIPK1-dependent cell death.
    Immunobiology. 226 (1), 1-7, 2021.
    Journal metrics:
    Q2 Hematology
    Q3 Immunology
    Q3 Immunology and Allergy
  2. Szöőr, Á., Szöllősi, J., Vereb, G.: From antibodies to living drugs: quo vadis cancer immunotherapy?.
    Biol. Futura. 72 (1), 85-99, 2021.
    Journal metrics:
    Q2 Agricultural and Biological Sciences (miscellaneous)
    Q3 Biochemistry, Genetics and Molecular Biology (miscellaneous)
2020
  1. Tóth, G., Szöllősi, J., Abken, H., Vereb, G., Szöőr, Á.: A Small Number of HER2 Redirected CAR T Cells Significantly Improves Immune Response of Adoptively Transferred Mouse Lymphocytes against Human Breast Cancer Xenografts.
    Int. J. Mol. Sci. 21 (3), 1-11, 2020.
    Journal metrics:
    Q2 Catalysis
    D1 Computer Science Applications
    D1 Inorganic Chemistry
    Q1 Medicine (miscellaneous)
    Q2 Molecular Biology
    D1 Organic Chemistry
    D1 Physical and Theoretical Chemistry
    D1 Spectroscopy
  2. Volpin, V., Michels, T., Sorrentino, A., Menevse, A., Knoll, G., Ditz, M., Milenkovic, V., Chen, C., Rathinasamy, A., Griewank, K., Boutros, M., Haferkamp, S., Berneburg, M., Wetzel, C., Seckinger, A., Hose, D., Goldschmidt, H., Ehrenschwender, M., Witzens-Harig, M., Szöőr, Á., Vereb, G., Khandelwal, N., Beckhove, P.: CAMK1D Triggers Immune Resistance of Human Tumor Cells Refractory to Anti-PD-L1 Treatment.
    Cancer Immunol. Res. 8 1163-1179, 2020.
    Journal metrics:
    D1 Cancer Research
    D1 Immunology
2019
  1. Méhes, E., Baráth, M., Gulyás, M., Bugyik, E., Geiszt, M., Szöőr, Á., Lányi, Á., Czirok, A.: Enhanced endothelial motility and multicellular sprouting is mediated by the scaffold protein TKS4.
    Sci. Rep. 9 (1), 1-13, 2019.
    Journal metrics:
    D1 Multidisciplinary
2017
  1. Velasquez, M., Szöőr, Á., Vaidya, A., Thakkar, A., Nguyen, T., Wu, M., Liu, H., Gottschalk, S.: CD28 and 41BB Costimulation Enhances the Effector Function of CD19-Specific Engager T Cells.
    Cancer Immunol. Res. 5 (10), 860-870, 2017.
    Journal metrics:
    D1 Cancer Research
    D1 Immunology
  2. Szöőr, Á., Vaidya, A., Velasquez, M., Mei, Z., Galvan, D., Torres, D., Gee, A., Heczey, A., Gottschalk, S.: T Cell-Activating Mesenchymal Stem Cells as a Biotherapeutic for HCC.
    Mol. Ther Oncolytics. 28 (6), 69-79, 2017.
    Journal metrics:
    Q2 Cancer Research
    Q2 Molecular Medicine
    Q2 Oncology
    Q1 Pharmacology (medical)
  3. Szöőr, Á., Velasquez, M., Bonifant, C., Vaidya, A., Brunetti, L., Gundry, M., Parihar, R., Goodell, M., Gottschalk, S.: Two-pronged Cell Therapy: engineering NK cells to target CD22 and redirect bystander T cells to CD19 for the adoptive immunotherapy of B-cell malignancies.
    J. Immunol. 198 (Suppl.), 198,6, 2017.
2016
  1. Bonifant, C., Szöőr, Á., Torres, D., Joseph, N., Velasquez, M., Iwahori, K., Gaikwad, A., Nguyen, T., Arber, C., Song, X., Redell, M., Gottschalk, S.: CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid Leukemia.
    Mol. Ther. 24 (9), 1615-1626, 2016.
    Journal metrics:
    D1 Drug Discovery
    D1 Genetics
    D1 Medicine (miscellaneous)
    Q1 Molecular Biology
    D1 Molecular Medicine
    D1 Pharmacology
Show all
updated: 2024-07-09, 01:07

SCImago quartiles of
scientific journal articles

Number of scientific articles: 32
Q1/D1 14 (43.8%)
Q1 27 (84.4%)
Q2 4 (12.5%)
N/A 1 (3.1%)
-
OK

SCImago subject areas and categories

Medicine (22)
Immunology and Allergy (9)
Medicine (miscellaneous) (7)
Oncology (7)
Pharmacology (medical) (2)
Cardiology and Cardiovascular Medicine (1)
Dermatology (1)
Hematology (1)
Biochemistry, Genetics and Molecular Biology (17)
Cancer Research (10)
Molecular Biology (4)
Molecular Medicine (4)
Biochemistry, Genetics and Molecular Biology (miscellaneous) (2)
Cell Biology (1)
Genetics (1)
Immunology and Microbiology (12)
Immunology (12)
Multidisciplinary (3)
Multidisciplinary (3)
Pharmacology, Toxicology and Pharmaceutics (3)
Pharmacology (3)
Drug Discovery (1)
Agricultural and Biological Sciences (2)
Agricultural and Biological Sciences (miscellaneous) (2)
Chemical Engineering (2)
Catalysis (2)
Chemistry (2)
Inorganic Chemistry (2)
Organic Chemistry (2)
Physical and Theoretical Chemistry (2)
Spectroscopy (2)
Computer Science (2)
Computer Science Applications (2)

Genre chart

Year chart

Language chart

iDEa co-authors

Show more

Other co-authors

Velasquez, Mireya Paulina
Bonifant, Challice Lee
Show more
Velasquez, Mireya Paulina
Bonifant, Challice Lee
Nguyen, Thi Le Phuong
Blokon-Kogan, Dayana
Cooper, Laurence J. N.
Csikó Kristóf György
Ehrenschwender, Martin
Goldschmidt, Hartmut
Haferkamp, Sebastian
Meilinger-Dobra Mónika
Milenkovic, Vladimir Milija
Nelhűbel Györgyi A.
Panoutsopoulou, Konstantina
Rathinasamy, Anchana
Rodriguez-Cruz, Tania
Vondalova, Blanarova O.
Weinstein-Marom, Hadas
Wetzel, Christian H.
Witzens-Harig, Mathias